FERUMOXYTOL - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ferumoxytol and what is the scope of freedom to operate?

Ferumoxytol is the generic ingredient in one branded drug marketed by Amag Pharms Inc and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ferumoxytol has thirteen patent family members in ten countries.

There is one drug master file entry for ferumoxytol. One supplier is listed for this compound.

Summary for FERUMOXYTOL

International Patents:	13
US Patents:	6
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	4
Clinical Trials:	69
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for FERUMOXYTOL
DailyMed Link:	FERUMOXYTOL at DailyMed

Recent Clinical Trials for FERUMOXYTOL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Auerbach Hematology Oncology Associates P C	Phase 3
Thomas Jefferson University	Phase 4
NYU Langone Health	Phase 4

See all FERUMOXYTOL clinical trials

Recent Litigation for FERUMOXYTOL

Identify potential future generic entrants

District Court Litigation

Case Name	Date
AMAG PHARMACEUTICALS, INC. v. SANDOZ INC.	2016-03-17

See all FERUMOXYTOL litigation

Pharmacology for FERUMOXYTOL

Drug Class	Parenteral Iron Replacement

Paragraph IV (Patent) Challenges for FERUMOXYTOL

Tradename	Dosage	Ingredient	NDA	Submissiondate
FERAHEME	SOLUTION;INTRAVENOUS	ferumoxytol	022180	2015-12-04

US Patents and Regulatory Information for FERUMOXYTOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009		RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009		RX	Yes	Yes	Start Trial	Start Trial	Y	Y		Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009		RX	Yes	Yes	Start Trial	Start Trial	Y	Y		Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FERUMOXYTOL

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	Start Trial	Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	Start Trial	Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	Start Trial	Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	Start Trial	Start Trial
Amag Pharms Inc	FERAHEME	ferumoxytol	SOLUTION;INTRAVENOUS	022180-001	Jun 30, 2009	Start Trial	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FERUMOXYTOL

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	2011046752	Start Trial
European Patent Office	1169062	Start Trial
Spain	2334555	Start Trial
European Patent Office	1522318	Start Trial
Cyprus	1109527	Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for FERUMOXYTOL

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1169062	1290043-7	Sweden	Start Trial	PRODUCT NAME: FERUMOXYTOL; REG. NO/DATE: EU/1/12/774/001 20120615
1169062	300558	Netherlands	Start Trial	PRODUCT NAME: FERUMOXYTOL IN IEDERE DOOR HET BASISOCTROOI BESCHERMDE VORM; REGISTRATION NO/DATE: EU/1/12/774/001-002 20120615
1169062	2012C/052	Belgium	Start Trial	PRODUCT NAME: FERUMOXYTOL; AUTHORISATION NUMBER AND DATE: EU/1/12/774/001 20120620
1169062	CA 2012 00050	Denmark	Start Trial
1169062	92114	Luxembourg	Start Trial	PRODUCT NAME: FERUMOXYTOL
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.